| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 03/27/2007 | US7196185 Preparing immunoglobulin as oral vaccines for cattle; animal husbandry; forensics |
| 03/27/2007 | US7196184 Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene |
| 03/27/2007 | US7196183 Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
| 03/27/2007 | US7196182 An isolated nucleic acid molecule comprising DNA encoding a polypeptide, and a hybride DNA; programmed cell death, cytokine processing and receptor signal transduction |
| 03/27/2007 | US7196171 Alstrom syndrome is a homogeneous autosomal recessive disorder characterized by childhood obesity associated with hyperinsulinemia, chronic hyperglycemia, and neurosensory deficiency; isolated polypeptide |
| 03/27/2007 | US7196164 Comprises nucleotide sequences coding signal sequence polypeptides for diagnosis, prevention and treatment of cell proliferative, cardiovascular and infectious disorders |
| 03/27/2007 | US7196069 High affinity RNA ligands of basic fibroblast growth factor |
| 03/27/2007 | US7196068 Downregulation of c-myc by promoting the ubiquitination of FBP, by administering an isolated p38/JTV-1protein or fragment or an isolated nucleic acid encoding said protein; |
| 03/27/2007 | US7196067 Which is complementary to a portion of the nucleic acid sequence encoding IGFBP-2 and which reduces the amount of IGFBP-2 in the treated cells; gene expression inhibition |
| 03/27/2007 | US7196066 eliciting an immune response in a subject by administering one or more large genomic DNA fragments; providing a core carrier coated with constructs carrying genomic DNA fragments obtained or derived from one or more pathogens |
| 03/27/2007 | US7195916 Method for expression of small antiviral RNA molecules within a cell |
| 03/27/2007 | US7195910 Central nervous system disorders; antidiabetic agents |
| 03/27/2007 | US7195908 Supports treated with triamine for immobilizing biomolecules |
| 03/27/2007 | US7195907 Non-ribosomal peptide synthetases and associated biosynthetic genes |
| 03/27/2007 | US7195904 Preparing hydroxynitrilase for generation of cyanohydrins; disease resistant plants |
| 03/27/2007 | US7195903 Comprises metallloenzyme which is fibrinolytically active (fibrolase), for use in treating blood clots in situ |
| 03/27/2007 | US7195901 nucleotide sequence that code for polypeptides having transferase enzyme activity, used to transform plants and microorganisms, and and shows selective action for hydroxylated fatty acyl glycerides; castor oil biosynthesis with by-product inhibition |
| 03/27/2007 | US7195900 Comprises enzymatic polypeptide with amino acid oxidase activity for preparation of chemical intermediates for antibiotics and hypotensive agents |
| 03/27/2007 | US7195897 Feedback-resistant homoserine transsuccinylases having a modified c-terminus |
| 03/27/2007 | US7195893 Nucleic acids encoding α2δ calcium channel subunits and methods for making and using them |
| 03/27/2007 | US7195892 Acylase gene |
| 03/27/2007 | US7195888 Determining if a compound is an anti-arrhythmia or myocardial salvage drug by detecting a change in enzyme expression level; quantifying release of fatty acids into the effluent of myocardium; animal models |
| 03/27/2007 | US7195887 Nucleic acid fragments encoding 1-deoxy-D-xylulose 5-phosphate synthase in plants and seeds; isopentenyl diphosphate biosynthetic enzymes; enzyme inhibitors |
| 03/27/2007 | US7195880 DNA-protein fusions and uses thereof |
| 03/27/2007 | US7195878 Device and method for fecal testing |
| 03/27/2007 | US7195877 Primer set for identifying allelic variation liver metabolic enzyme; screening for antiarrhythmics, beta -receptor blockers, neuroleptics, serotonin reuptake inhibitors and antidepressants |
| 03/27/2007 | US7195876 Comprises chimeric fusion protein composed of tyrosine kinase domain for diagnosis, prevention and treatment of tumors |
| 03/27/2007 | US7195875 Bioassay for sorting, detecting and identifying analytes; genomics |
| 03/27/2007 | US7195874 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures |
| 03/27/2007 | US7195869 Comprises fusion proteins with green fluorescent protein to construct gene expression library; transcription factors; for treating tumor necrosis factor-related diseases |
| 03/27/2007 | US7195867 Method for detection of multiple test materials in a sample |
| 03/27/2007 | US7195765 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 03/27/2007 | CA2275489C Oil bodies and associated proteins as affinity matrices |
| 03/27/2007 | CA2200582C Dna encoding human papillomavirus type 6a |
| 03/22/2007 | WO2007032817A2 Pure mirna sample preparation method |
| 03/22/2007 | WO2007032793A1 Multiplex array useful for assaying protein-protein interaction |
| 03/22/2007 | WO2007031091A2 Rna antagonist compounds for the modulation of p21 ras expression |
| 03/22/2007 | WO2006130472A3 Identification of rac1b as a marker and mediator of matrix metalloproteinase-induced malignancy |
| 03/22/2007 | WO2006121773A3 Compositions and assays to detect influenza virus a and b nucleic acids |
| 03/22/2007 | WO2006115951A3 Ubiquilin regulation of presenilin endoproteolysis, and suppression of polyglutamine-induced toxicity in cells |
| 03/22/2007 | WO2006094056A3 Enzyme amplified electrochemical dna detection |
| 03/22/2007 | WO2006066214A3 Use of flagellin in the immunotherapy of yersinia pestis |
| 03/22/2007 | WO2006055351A3 Structure-based compound design involving riboswitches |
| 03/22/2007 | WO2006053343A3 Inflammation models in neurodegenerative and arthritic disorders |
| 03/22/2007 | WO2005060536A3 si-RNA-MEDIATED GENE SILENCING TECHNOLOGY TO INHIBIT TYROSINASE AND REDUCE PIGMENTATION |
| 03/22/2007 | WO2004009837A3 A high resolution typing system for pathogenic mycobacterium tuberculosum |
| 03/22/2007 | US20070067867 Gene cluster involved in biosynthesis of isopentenyl diphosphate in the non-mevalonate pathway of Hevea brasiliensis |
| 03/22/2007 | US20070067866 Gene cluster of prenyl transferase from Hevea brasiliensis |
| 03/22/2007 | US20070067865 Annotated plant genes |
| 03/22/2007 | US20070067864 Cytochrome P450 oxygenases and their uses |
| 03/22/2007 | US20070067858 Novel il-8-like polypeptides |
| 03/22/2007 | US20070067857 Therapeutic agent for NGF |
| 03/22/2007 | US20070067856 Therapeutic agent for NGF |
| 03/22/2007 | US20070067109 Reading multiple chemical arrays |
| 03/22/2007 | US20070066805 Human tumor necrosis factor receptor |
| 03/22/2007 | US20070066804 Polypeptide of given sequence; inducing HLA (human leukocyte antigen) restricted cytotoxic T lymphocytes |
| 03/22/2007 | US20070066803 Method to control tumor progression and invasiveness |
| 03/22/2007 | US20070066801 Identification of reagents for the diagnosis and study of francisella |
| 03/22/2007 | US20070066800 Apo2l(trail) receptor binding peptides and uses thereof |
| 03/22/2007 | US20070066565 Cyclic maltosylmatose |
| 03/22/2007 | US20070066557 Modulation of glucocorticoid receptor expression |
| 03/22/2007 | US20070066553 Immunostimulatory nucleic acid molecules |
| 03/22/2007 | US20070066551 Aptamer medicinal chemistry |
| 03/22/2007 | US20070066550 Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics |
| 03/22/2007 | US20070066549 Modified antisense oligonucleotide; antitumor and anticancer agents |
| 03/22/2007 | US20070066547 Ligands |
| 03/22/2007 | US20070066531 Enhanced membrane binding affinityl blood coagulation |
| 03/22/2007 | US20070066520 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 03/22/2007 | US20070065928 DNA, nucleaotides sequences and polynucleotides that code for sugar metabolism and oxidative phosphorylation proteins; genetic engineered microorganisms used for biosynthesis of amino acids |
| 03/22/2007 | US20070065920 For treatment of microbial conditions (including malaria), proliferative disorders, inappropiate vascularisation, inhibition of angiogenesis; |
| 03/22/2007 | US20070065918 Purified mammalian cytokines; related reagents and methods |
| 03/22/2007 | US20070065917 Endogenous and non-endogenous, constitutively activated human G protein-coupled receptions |
| 03/22/2007 | US20070065916 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids |
| 03/22/2007 | US20070065915 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 03/22/2007 | US20070065914 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 03/22/2007 | US20070065913 Isolation of binding proteins with high affinity to ligands |
| 03/22/2007 | US20070065912 Multiple Gene Expression including sORF Constructs and Methods with Polyproteins, Pro-Proteins, and Proteolysis |
| 03/22/2007 | US20070065910 bacterium or yeast cells genetically engineered to express mutated chorismate mutase/prephenate dehydrogenase, used in the production of tyrosine-enriched foods or nutraceuticals |
| 03/22/2007 | US20070065909 Prokaryotically produced antibodies and uses thereof |
| 03/22/2007 | US20070065908 antiinflammatories, antiviral agents; coadministering with antibiotic; surface decontamination |
| 03/22/2007 | US20070065906 Process for producing heterologous protein in e. coli |
| 03/22/2007 | US20070065905 Process for expression and secretion of proteins by the non-conventional yeast zygosaccharomyces bailii |
| 03/22/2007 | US20070065904 Recombinant expression vectors for functional nav1.9 sodium channels |
| 03/22/2007 | US20070065903 Process for chromosomal expression of foreign genes in the hsdM region of a methylotrophic microbial host cell |
| 03/22/2007 | US20070065902 Process for chromosomal expression of foreign genes in the fliC region of a methylotrophic microbial host cell |
| 03/22/2007 | US20070065897 Human PRSS11-like S2 serine protease and uses thereof |
| 03/22/2007 | US20070065887 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/22/2007 | US20070065875 NTB-A, a surface molecule involved in natural killer cells activity |
| 03/22/2007 | US20070065873 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators |
| 03/22/2007 | US20070065871 Human T2R71 receptor and related assays for identifying human bitter taste modulators |
| 03/22/2007 | US20070065870 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065867 Promoter and plasmid system for genetic engineering |
| 03/22/2007 | US20070065853 For detection of nucleic acid marker molecules; used to rapidly identify TSE-infected cattle; amplifying and monitoring the development of specific amplification products |
| 03/22/2007 | US20070065851 Method for detecting a microorganism in a fecal specimen |
| 03/22/2007 | US20070065849 Nucleic acid encoding eosinophil eotaxin receptor |
| 03/22/2007 | US20070065848 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor |
| 03/22/2007 | US20070065841 Methods and compositions for the removal of nucleic acid amplification inhibitors |
| 03/22/2007 | US20070065840 Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAS and their target mRNAS |
| 03/22/2007 | US20070065838 Oligonucleotide mediated nucleic acid recombination |